Entera Bio raises ~$6.6M in registered direct offering; issues shares and warrants

Entera Bio Ltd.

Aggregate proceeds ~$6.6M from sale of 7,916,879 units at $0.835 each.
Each unit includes one ordinary share (or pre-funded warrant) and one five-year warrant to purchase an ordinary share at $1.00.
Warrants exercisable immediately; if all for cash, additional ~$7.9M potential proceeds.
CEO Miranda Toledano and Chairman Gerald Lieberman participated in the placement.
Company to file resale registration statement within 30 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.